Clinical Trials on Cirrhotic Patients With Ascites in Brazil
Total 8 results
-
SanofiCompletedLiver Cirrhosis | AscitesUnited States, France, Brazil, Poland, Romania, Russian Federation, Italy, Netherlands, Portugal, Sweden, Belgium, Argentina, Croatia, Denmark, Hungary, Israel, Spain, Chile, Canada, United Kingdom, Australia
-
AstraZenecaCompletedPatients With DyslipidemiaBrazil
-
University of Sao PauloUniversity of Sao Paulo General HospitalCompletedLiver Cirrhosis | Heart Failure | Ascites | CarcinomatosisBrazil
-
SanofiTerminatedLiver Cirrhosis | AscitesFrance, Canada, Brazil, Poland, Romania, Russian Federation, Australia, Germany, Spain, Turkey, Bulgaria, Malaysia, Serbia, Singapore, Belgium, Czech Republic, Mexico, Chile, United States, Argentina, Bosnia and Herzegovina
-
Instituto do Cancer do Estado de São PauloUnknownPatients Diagnosed With Advanced Carcinoma of Uterine Cervix tBrazil
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B | Relatives to/Carers of PatientsBrazil
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe Patients Untreated or Treated With rhGAASpain, Slovenia, Serbia, Korea, Republic of, Greece, Australia, Singapore, Brazil, Canada, Taiwan, Ireland, Poland, Romania